1. Home
  2. AGIO vs CENTA Comparison

AGIO vs CENTA Comparison

Compare AGIO & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • CENTA
  • Stock Information
  • Founded
  • AGIO 2007
  • CENTA 1955
  • Country
  • AGIO United States
  • CENTA United States
  • Employees
  • AGIO N/A
  • CENTA N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • CENTA Consumer Specialties
  • Sector
  • AGIO Health Care
  • CENTA Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • AGIO 2.4B
  • CENTA 2.2B
  • IPO Year
  • AGIO 2013
  • CENTA 1993
  • Fundamental
  • Price
  • AGIO $41.33
  • CENTA $29.06
  • Analyst Decision
  • AGIO Hold
  • CENTA Strong Buy
  • Analyst Count
  • AGIO 5
  • CENTA 4
  • Target Price
  • AGIO $52.50
  • CENTA $45.50
  • AVG Volume (30 Days)
  • AGIO 585.1K
  • CENTA 381.0K
  • Earning Date
  • AGIO 10-31-2024
  • CENTA 11-18-2024
  • Dividend Yield
  • AGIO N/A
  • CENTA N/A
  • EPS Growth
  • AGIO N/A
  • CENTA 42.23
  • EPS
  • AGIO N/A
  • CENTA 2.71
  • Revenue
  • AGIO $31,306,000.00
  • CENTA $3,281,118,000.00
  • Revenue This Year
  • AGIO $44.80
  • CENTA N/A
  • Revenue Next Year
  • AGIO $174.95
  • CENTA $1.73
  • P/E Ratio
  • AGIO N/A
  • CENTA $10.77
  • Revenue Growth
  • AGIO 55.39
  • CENTA 0.42
  • 52 Week Low
  • AGIO $19.80
  • CENTA $27.88
  • 52 Week High
  • AGIO $53.29
  • CENTA $41.03
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 37.77
  • CENTA 22.42
  • Support Level
  • AGIO $40.37
  • CENTA $31.51
  • Resistance Level
  • AGIO $46.24
  • CENTA $32.56
  • Average True Range (ATR)
  • AGIO 2.35
  • CENTA 0.81
  • MACD
  • AGIO -0.66
  • CENTA -0.34
  • Stochastic Oscillator
  • AGIO 7.39
  • CENTA 1.44

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: